
Journal of Heterocyclic Chemistry p. 649 - 652 (1997)
Update date:2022-08-05
Topics:
Moniz, George A.
Hammond, Gerald B.
Aminoglutethimide [3-(4-aminophenyl)-3-ethylpiperidine-2,6-dione] has been used clinically in the treatment of metastatic breast carcinoma. Inhibition of tumor growth is due to interference with estrogen biosynthesis. However, its action is not specific and its metabolism gives rise to toxic and non-inhibitory metabolites. We sought to explore the impact of relocating the amino group in aminoglutethimide to the ethyl side chain. To that end, we now report the synthesis and aromatase-inhibitory activity of 3-(2′-N,N-diethylamino)ethyl-3-phenylpiperidine-2,6-dione 5. The introduction of the amino functionality on the ethyl group is accomplished via reductive amination of aldehyde 8, prepared in three steps from benzyl cyanide, The synthetic route presented can be used for the preparation of related derivatives of azninoglutethimide.
View MoreHEZE KINGVOLT CHEMICAL CO., LTD
Contact:86-573-82118911
Address:Juancheng Industry Park
Zhenjiang Haitong Chemical Industry Co., Ltd.
Contact:+86 (511) 8448-0369
Address:Baoyan Town, Dantu District, Zhenjiang City, Jiangsu, China
Contact:+86-25-83719363
Address:106-7 Chunnan Rd, Chunxi Town, Gaochun, Nanjing, China
Contact:+86-13666670345
Address:Agricultural Development Zone, Haining, Jiaxing, Zhejiang
website:http://www.fwdchem.com
Contact:86-21-54450828
Address:Room 802,Lotus Tower ,159 Tianzhou Road,Xuhui District,Shanghai
Doi:10.1021/jm960850i
(1997)Doi:10.1016/S0960-894X(97)00245-X
(1997)Doi:10.1021/jo01258a049
(1969)Doi:10.1002/hlca.19970800304
(1997)Doi:10.1016/S0040-4039(97)00777-6
(1997)Doi:10.1139/v68-306
(1968)